Skip to content

ImmuneWatch: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ImmuneWatch

BE 0774.472.942
NACE 72.101, Research and development on biotechnology
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€8,523
2024 · -€80,581+€89,104
Equity
-€30,203
2024 · -€38,726+€8,523
Cash
€59,129
2024 · €222,439-€163,310
Balance sheet total
€173,740
2024 · €299,800-€126,060

Largest movements

2024 to 2025
Assets
  • Cash -€163,310

    down €163,310 (-73.4%), from €222,439 to €59,129

    mainly Investment in fixed assets (net) (-€221,593) and Accrued charges and deferred income (-€137,422)

  • Receivables within one year +€21,127

    up €21,127 (+65.6%), from €32,223 to €53,350

    of which Other amounts receivable: +€27,627

  • Intangible fixed assets +€11,190

    up €11,190 (+95.3%), from €11,747 to €22,937

  • Receivables after one year +€8,565

    up €8,565 (+43.9%), from €19,491 to €28,056

Equity and liabilities
  • Accrued charges and deferred income -€137,422

    down €137,422 (-49.0%), from €280,180 to €142,758

  • Debts after one year -€15,000

    down €15,000 (-100.0%), from €15,000 to €0

  • Current portion of long-term debt +€15,000

    new in 2025: €15,000

  • Profit (loss) carried forward +€8,523

    up €8,523 (+3.2%), from -€270,305 to -€261,782

Income statement
  • Gross operating margin +€162,567

    up €162,567 (+147.9%), from €109,909 to €272,476

  • Depreciation +€69,774

    up €69,774 (+49.3%), from €141,508 to €211,282

  • Staff costs +€5,669

    up €5,669 (+11.2%), from €50,611 to €56,281

  • Taxes -€3,723

    down €3,723 (-85.7%), from -€4,346 to -€8,069

  • Financial charges +€3,515

    up €3,515 (+164.5%), from €2,136 to €5,652

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€80,581
Gross operating margin +€162,567
Staff costs -€5,669
Depreciation -€69,774
Other operating charges -€14
Financial income +€1,788
Financial charges -€3,515
Taxes +€3,723
Result 2025 €8,523

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€58,283
Investment -€221,593
Financing €0
Cash 2024 €222,439
Net result for the year +€8,523
Depreciation +€211,282
Receivables after one year -€8,565
Receivables within one year -€21,127
Deferred charges and accrued income +€2,753
Trade debts +€1,907
Tax, wage and social debts +€735
Other debts +€197
Accrued charges and deferred income -€137,422
Investment in fixed assets (net) -€221,593
Debts after one year -€15,000
Current portion of long-term debt +€15,000
Cash 2025 €59,129
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €299,800 €173,740 -€126,060 -42.0%
Fixed assets 21/28 €14,091 €24,402 +€10,311 +73.2%
Intangible fixed assets 21 €11,747 €22,937 +€11,190 +95.3%
Tangible fixed assets 22/27 €2,344 €1,464 -€880 -37.5%
Furniture and vehicles 24 €2,344 €1,464 -€880 -37.5%
Current assets 29/58 €285,709 €149,339 -€136,371 -47.7%
Amounts receivable after more than one year 29 €19,491 €28,056 +€8,565 +43.9%
Other amounts receivable 291 €19,491 €28,056 +€8,565 +43.9%
Amounts receivable within one year 40/41 €32,223 €53,350 +€21,127 +65.6%
Trade receivables 40 €21,257 €14,757 -€6,500 -30.6%
Other amounts receivable 41 €10,966 €38,593 +€27,627 +251.9%
Cash at bank and in hand 54/58 €222,439 €59,129 -€163,310 -73.4%
Deferred charges and accrued income 490/1 €11,557 €8,804 -€2,753 -23.8%
Total equity and liabilities 10/49 €299,800 €173,740 -€126,060 -42.0%
Equity 10/15 -€38,726 -€30,203 +€8,523 +22.0%
Contributions 10/11 €231,579 €231,579 = 0.0%
Profit (loss) carried forward 14 -€270,305 -€261,782 +€8,523 +3.2%
Amounts payable 17/49 €338,526 €203,943 -€134,583 -39.8%
Amounts payable after more than one year 17 €15,000 €0 -€15,000 -100.0%
Financial debts 170/4 €15,000 €0 -€15,000 -100.0%
Amounts payable within one year 42/48 €43,347 €61,185 +€17,839 +41.2%
Current portion of amounts payable after more than one year 42 - €15,000 +€15,000
Trade debts 44 €36,198 €38,105 +€1,907 +5.3%
Suppliers 440/4 €36,198 €38,105 +€1,907 +5.3%
Taxes, remuneration and social security 45 €7,090 €7,825 +€735 +10.4%
Remuneration and social security 454/9 €7,090 €7,825 +€735 +10.4%
Other amounts payable 47/48 €58 €255 +€197 +338.5%
Accrued charges and deferred income 492/3 €280,180 €142,758 -€137,422 -49.0%
Remuneration, social security and pensions 62 €50,611 €56,281 +€5,669 +11.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €141,508 €211,282 +€69,774 +49.3%
Other operating charges 640/8 €580 €595 +€14 +2.5%
Gross operating margin 9900 €109,909 €272,476 +€162,567 +147.9%
Operating profit (loss) 9901 -€82,791 €4,318 +€87,109
Financial income 75/76B €0 €1,788 +€1,788
Recurring financial income 75 €0 €1,788 +€1,788
Financial charges 65/66B €2,136 €5,652 +€3,515 +164.5%
Recurring financial charges 65 €2,136 €5,652 +€3,515 +164.5%
Profit (loss) for the period before taxes 9903 -€84,927 €454 +€85,381
Income taxes 67/77 -€4,346 -€8,069 -€3,723 -85.7%
Profit (loss) for the period 9904 -€80,581 €8,523 +€89,104
Profit (loss) for the period to be appropriated 9905 -€80,581 €8,523 +€89,104

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.